Taiwan has secured preferential treatment for its semiconductor exports under a January trade deal with the US, ensuring favourable terms s...

Investors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...

A trade think tank, GTRI, advises India against rushing into a bilateral trade agreement with the US due to President Trump's unstable tari...

The Indo-Pacific Economic Framework for Prosperity, widely known as IPEF, faces significant hurdles. Recent analyses indicate that the foun...

US stock market surging big today. Dow Jones, S&P 500 and Nasdaq rally as Dow jumps record 500 points. A powerful mix of blowout earnings, ...

The lines between economics and strategy have blurred, as highlighted in CUTS International's geoeconomic webinar. Experts discussed how tr...

A recent CUTS International webinar under its Geoeconomic Monograph Series highlighted how global economics and geopolitics are now deeply ...

Trump is rapidly expanding Section 232 tariffs on diverse imports, including pharmaceuticals and machinery, as a backup against potential S...

U.S. Commerce Secretary Howard Lutnick said tariff revenues may rise to $50 billion a month as higher duties on imports from multiple count...

Pharma stocks such as Sun Pharma, Cipla, Dr Reddy’s Laboratories, Lupin, and others will be in focus on Wednesday after US President Donald...

U.S. President Donald Trump said new tariffs on imported pharmaceuticals will start small but could rise to 250% within 18 months to boost ...

At a Cabinet meeting earlier this month, Trump said he planned to impose a 50% tariff on copper in the coming weeks, and that he expected p...

The Trump administration is advancing tariff plans by investigating imports of computer chips, chip-making equipment, and pharmaceuticals u...

President Trump announced potential tariffs on imported pharmaceuticals, impacting countries like India, a major supplier to the US drug ma...

The Trump administration is initiating investigations into pharmaceutical and semiconductor imports, potentially leading to tariffs based o...

Indian pharmaceutical companies are crucial to the U.S. healthcare system, filling four out of every ten prescriptions in 2022. Reports ind...

Donald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to relocate operations ...